Effects of TOA Versus PNF Techniques on Trunk Control in Children With Hemiplegic Cerebral Palsy

R

Riphah International University

Status

Completed

Conditions

Hemiplegic Cerebral Palsy

Treatments

Device: Group A
Device: Group B

Study type

Interventional

Funder types

Other

Identifiers

NCT06232330
REC/RCR&AHS/23/0738

Details and patient eligibility

About

Cerebral palsy occurs in 2-2.5 per 1000 live births, seems to be the most common cause of lifelong physical disability, and has an impact on the child, caregivers, and society. The incidence of cerebral palsy continues to rise owing to the large numbers of premature and high-risk infants who survive. Task-oriented arm approaches promote intensive, meaningful, and goal-oriented training in subjects, and the voluntary functional activities of these subjects possibly reduce their motor disabilities.

Full description

The study will be randomized clinical trial used to evaluate the effectiveness of TOA and PNF on trunk control in children with hemiplegic cerebral palsy. Subjects with hemiplegic cerebral palsy meeting the inclusion and exclusion criteria will be divided into two groups using non- probability sampling techniques. Assessment will be done using trunk control measuring scale and pediatric reach test . Group A will receive TOA and conventional therapy and Group B will receive PNF and conventional therapy.

Enrollment

28 patients

Sex

All

Ages

6 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The level of gross motor function between I and III in accordance with the Gross Motor Function Classification System (GMFCS)
  • The degree of spasticity in the affected lower extremity between grade 1 and 1+ in accordance with the Modified Ashworth scale
  • 6-12 years of age
  • Ability to understand and follow verbal instructions

Exclusion criteria

  • Surgical procedures within the past 6 months
  • Botox injection within 6 months
  • Unstable Seizures
  • Other comorbidity condition (Multiple Disabilities)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

28 participants in 2 patient groups

Group A
Experimental group
Description:
TOA and conventional therapy
Treatment:
Device: Group A
Group B
Experimental group
Description:
PNF and conventional therapy
Treatment:
Device: Group B

Trial contacts and locations

1

Loading...

Central trial contact

Muhammad Asif Javed, MS; Imran Amjad, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems